HERON THERAPEUTICS, INC. /DE/ SEC Schedule, 12-09, Valuation Allowances and Reserves, Period Increase (Decrease)
HERON THERAPEUTICS, INC. /DE/ (HRTX) reported SEC Schedule, 12-09, Valuation Allowances and Reserves, Period Increase (Decrease) of $8.90 million for the 12-month period ending 2012-12-31, per its 10-K filed 2013-03-01.
Discontinued › Notes
us-gaap:ValuationAllowancesAndReservesPeriodIncreaseDecrease · last filed 2013-03-01
- HERON THERAPEUTICS, INC. /DE/ sec schedule, 12-09, valuation allowances and reserves, period increase (decrease) for fiscal 2012 was $8.90M.
- HERON THERAPEUTICS, INC. /DE/ sec schedule, 12-09, valuation allowances and reserves, period increase (decrease) for fiscal 2011 was -$17.30M, a 2571.43% decline from fiscal 2010.
- HERON THERAPEUTICS, INC. /DE/ sec schedule, 12-09, valuation allowances and reserves, period increase (decrease) for fiscal 2010 was $700.00K.
| Period end | SEC Schedule, 12-09, Valuation Allowances and Reserves, Period Increase (Decrease) 12 month |
|---|---|
| 2012-12-31 | $8.90M 10-K · filed 2013-03-01 |
| 2011-12-31 | -$17.30M 10-K · filed 2013-03-01 |
| 2010-12-31 | $700.00K 10-K · filed 2013-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |
| Serina Therapeutics, Inc. (SER) | United States | $0.054B | -2.35 |
| Annovis Bio, Inc. (ANVS) | United States | $0.056B | -1.58 |
| Xilio Therapeutics, Inc. (XLO) | United States | $0.052B | |
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| TALPHERA, INC. (TLPH) | United States | $0.060B | |
| Elicio Therapeutics, Inc. (ELTX) | United States | $0.049B | |
| CalciMedica, Inc. (CALC) | United States | $0.061B | -1.42 |
| Lite Strategy, Inc. (LITS) | United States | $0.049B |